IFN-alpha-mediated increase in cytolytic activity of maturing NK cell upon exposure to HSV-infected myelomonocytes. 2009

Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
Istituto Giannina Gaslini, Genova, Italy.

Impaired control of chronic pathogen replication may be associated to alterations of NK-cell function. Whether mechanisms underlying this dysfunction involve perturbations of differentiating NK cells is still unknown. We studied an "in vitro" model of differentiation from CD34(+)Lin(-) precursors growing only myelomonocytes and maturing NK cells and where myelomonocytes could be suitably infected with HSV, HIV, or vaccinia. Cultures were evaluated by cytofluorometry and cytotoxicity assays for perturbations in differentiating NK cells. Increased expression of natural cytotoxicity receptors on maturing NK cells with increased cytolytic activity was observed with HSV-1 infection, and with vaccinia while no modulation of NK-cell phenotype nor cytotoxic activity were evident with an ssRNA lentivirus (HIV-1). In the presence of constant IL-12 and IL-15 concentrations, the observed effect did not require cell contact, involved IFN-alpha and was not reproduced by the addition of TLR9 agonist, nor blocked by TLR9 antagonists. Virus replication at sites of NK-cell precursor development may have different outcomes depending on the interaction between invading viruses and maturing NK cells. Thus, NK-cell precursors may be involved in the immune response to dsDNA viruses and possibly contribute to efficient control of virus infection.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014615 Vaccinia The cutaneous and occasional systemic reactions associated with vaccination using smallpox (variola) vaccine. Vaccinias
D014616 Vaccinia virus The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS. Buffalopox virus,Poxvirus officinale,Rabbitpox virus,Buffalo Pox Virus,Rabbit Pox Virus,Buffalo Pox Viruses,Buffalopox viruses,Rabbit Pox Viruses,Rabbitpox viruses,Vaccinia viruses,Virus, Buffalo Pox,Viruses, Buffalo Pox,virus, Buffalopox
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
January 2020, Cellular and molecular life sciences : CMLS,
Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
March 2009, Journal of leukocyte biology,
Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
March 2013, PLoS pathogens,
Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
March 2004, Journal of immunology (Baltimore, Md. : 1950),
Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
October 2015, Cellular immunology,
Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
July 1998, International immunology,
Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
June 2004, Journal of neuroimmunology,
Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
January 1995, Bollettino della Societa italiana di biologia sperimentale,
Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
August 2007, Journal of immunology (Baltimore, Md. : 1950),
Paola Costa, and Simona Sivori, and Federica Bozzano, and Isabella Martini, and Alessandro Moretta, and Lorenzo Moretta, and Andrea De Maria
September 1997, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!